RA-223 dichloride xofigo
Ended Awarded Last action
- Contract number
- 36C26319N0428
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $160,446
Award facts
- Contract value 100% obligated
- $160,445.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whippany, Hanover, NJ 07981, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$0 | |
| Original award | $160,446 |
About this award
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of the drug RA-223 Dichloride (Xofigo), which is used to treat prostate cancer. The contract has a firm fixed-price of $160,445.83 and a completion date of May 27, 2019. The contract was awarded on December 10, 2018 and was not set aside for small businesses. Bayer Healthcare Pharmaceuticals Inc. is the prime contractor and will perform the work at its facility in Whippany, New Jersey. This contract is likely part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract or Blanket Purchase Agreement (BPA) that Bayer Healthcare Pharmaceuticals Inc. holds with the VA and the Defense Logistics Agency (DLA) to provide a variety of pharmaceutical products, including specialty drugs like Xofigo, to support the healthcare needs of veterans and active duty military personnel.
Quick answers
Who was awarded contract 36C26319N0428?
36C26319N0428 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on December 10, 2018.
How much is contract 36C26319N0428 worth?
The government has obligated $160,446 on 36C26319N0428.
Is contract 36C26319N0428 an order under another contract?
Yes. 36C26319N0428 is a delivery order under V797P2202D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26319N0428 competed?
The extent of competition for 36C26319N0428 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award